The Future of Immune Checkpoint Inhibition in Gastric and Esophageal Cancers

Video

Geoffrey Y. Ku, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the future of immune checkpoint inhibition in gastric and esophageal cancers.

Related Videos
Related Content